Clik here to view.
Alvogen和Lotus宣布率先在欧洲发售Navelbine®软胶囊仿制品
新泽西州松溪镇 (美国商业资讯)–Alvogen今天宣布，其子公司Lotus Pharmaceuticals已在欧洲开售长春瑞滨(Vinorelbine) 20、30和80毫克软胶囊。该产品是Pierre Fabre Médicament公司的Navelbine®的仿制品，适用于治疗晚期非小细胞肺癌(NSCLC)和晚期乳腺癌。该产品是Navelbine®仿制品首次在欧洲发售。...
View ArticleClik here to view.
Clik here to view.
Worldwide Clinical Trials Hires Hiromi Wakita, Ph.D., to Lead Clinical...
MORRISVILLE, N.C. Worldwide Clinical Trials, Inc., (Worldwide) an award-winning, full-service, midsize, global contract research organization (CRO), announced today that Hiromi Wakita, Ph.D., has...
View ArticleClik here to view.
India’s Leading Pharmaceutical Services Company, Sai Life Sciences, Adopts...
FORT LAUDERDALE, Fla. & HYDERABAD, India ProcessMAP Corporation, the industry leader in cloud-based data intelligence platform for Environmental Health and Safety and Quality (EHSQ) announced...
View ArticleClik here to view.
Cook Medical Awarded Prestigious WELL Certification for Hong Kong Office
HONG KONG Cook Medical announced today that it has been awarded WELL Certification at the Silver level by the International WELL Building InstituteTM (IWBI) for its office in Hong Kong. The...
View ArticleClik here to view.
Kraig Biocraft Laboratories Completes Construction of Spider Silk Biotech...
ANN ARBOR, Mich. Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has completed construction of its new biotech...
View ArticleClik here to view.
Lilly Malaysia and Lilly Singapore Recognized as One of the Best Places to...
KUALA LUMPUR, Malaysia & SINGAPORE Eli Lilly (Malaysia) Sdn Bhd Malaysia and Eli Lilly Singapore Pte Ltd, local affiliates of the global pharmaceutical firm, Eli Lilly and Company with its...
View ArticleClik here to view.
Propanc Biopharma Completes Development of Bio-analytical Assay Method to...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer,...
View ArticleClik here to view.
マシモ、非侵襲的・連続的ヘモグロビン測定値（SpHb®）が新生児適応のCEマークを取得したと発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、新生児・乳児患者（3...
View ArticleClik here to view.
Masimo宣布无创连续血红蛋白监测(SpHb®)用于新生儿适应证获得CE标记
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，无创连续血红蛋白监测SpHb®...
View ArticleClik here to view.
China National Medical Products Administration Approves Biktarvy®...
FOSTER CITY, Calif. Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the China National Medical Products Administration (NMPA) has approved Biktarvy® (bictegravir 50mg/emtricitabine...
View ArticleClik here to view.
Great Bay Bio Adds Two Industry Leaders to Advisory Board
HONG KONG Great Bay Bio, a leading AI biotechnology company dedicated to big data-driven CMC (Chemistry Manufacturing and Controls) development of innovative biologics, is pleased to announce the...
View ArticleClik here to view.
China National Medical Products Administration Grants Innovative Medical...
SHANGHAI & ST. HELIER, Jersey Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company with...
View ArticleClik here to view.
From Infertility to Pregnancy at Half the US Cost: Bumrungrad International...
HASBROUCK HEIGHTS, N.J. & BANGKOK Thousands of couples from the United States and worldwide are realizing their dreams to create a family, thanks to the Fertility and IVF Clinic (the Clinic)...
View ArticleClik here to view.
Terns Pharmaceuticals Announces Positive Interim Results From Ongoing Phase 1...
FOSTER CITY, Calif. & SHANGHAI Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis...
View ArticleClik here to view.
Terns Pharmaceuticals拓臻生物公布其针对NASH适应症的候选药物SSAO抑制剂TERN-201的一期临床试验中期阳性结果
美国加州福斯特城与中国上海 (美国商业资讯)–Terns Pharmaceuticals 拓臻生物—一家专注非酒精性脂肪性肝炎（NASH）和癌症创新疗法研发的全球生物制药公司，今天公布其针对非酒精性脂肪性肝炎（NASH）适应症的候选药物，氨基脲敏感胺氧化酶（SSAO）抑制剂TERN-201的一期临床试验中期结果。...
View ArticleClik here to view.
Terns Pharmaceuticals、NASH治療薬として開発中のSSAO阻害剤TERN-201の進行中の第1相臨床試験から得た良好な中間結果を発表
米カリフォルニア州フォスターシティ & 上海 （ビジネスワイヤ） — 非アルコール性脂肪肝炎（NASH）とがんの革新的治療薬の創薬と開発に取り組む世界的バイオ製薬会社のTerns Pharmaceuticals,...
View ArticleClik here to view.
D&D Pharmatech Raises $137.1M in Series B Financing to Advance Potential...
GYEONGGI-DO, Korea & GERMANTOWN, Md. D&D Pharmatech Inc., a clinical-stage biotechnology company focused on development and commercialization of revolutionary medicines, and parent company...
View ArticleClik here to view.
Bio-Thera Solutions Initiates Phase I Clinical Trial for BAT2506, a Proposed...
GUANGZHOU, China Bio-Thera Solutions, a clinical-stage pharmaceutical company, today announced that dosing has begun in a Phase I clinical study to compare the pharmacokinetics and safety of...
View ArticleClik here to view.
2019 Edogawa NICHE Prize Awarded to Dr. Steven Rosenberg for His Pioneering...
TOKYO The Edogawa NICHE Committee today announced that the 2019-Edogawa NICHE Prize (www.edogawanicheprize.org) has been awarded to Dr. Steven A. Rosenberg, for his pioneering work in developing...
View Article